HELLING LARRY J
Known title: CEO, QCRH & CRBTCIK: 0001222102
HELLING LARRY J's purchase track record
How the stock did after each of HELLING LARRY J's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
10
of 10 since December 16, 2022
Stock higher 6 months later
90%
3 months: 60%
Median 6-month return
+16.6%
3 months: +5.5%
Beat the S&P 500
50%
median +0.1% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/28/2025 | QCRH | $65K | +14.2% | +17.2% | +24.3% |
| 2/5/2024 | QCRH | $56K | +2.7% | +23.2% | +4.9% |
| 10/31/2023 | QCRH | $48K | +30.7% | +16.1% | +20.1% |
| 9/8/2023 | QCRH | $50K | +8.2% | +14.2% | +14.9% |
| 8/23/2023 | QCRH | $51K | -1.8% | +8.6% | +12.3% |
| 7/31/2023 | QCRH | $51K | -6.6% | +22.0% | +7.4% |
| 5/26/2023 | QCRH | $40K | +32.4% | +28.7% | +8.4% |
| 5/2/2023 | QCRH | $39K | +33.7% | +22.6% | +1.8% |
| 3/17/2023 | QCRH | $45K | -0.7% | +14.7% | +13.6% |
| 12/16/2022 | QCRH | $48K | -9.0% | -9.7% | +14.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| QCRH | ▲ Buy | Open Market | 1,000 | $65K | 4/28/2025 | View on chart |
| QCRH | ▲ Buy | Option Exercise | 3,215 | $56K | 1/27/2025 | View on chart |
| QCRH | ▼ Sell | Tax Withholding | 1,508 | $119K | 1/27/2025 | View on chart |
| QCRH | ▲ Buy | Option Exercise | 3,500 | $61K | 7/17/2024 | View on chart |
| QCRH | ▼ Sell | Tax Withholding | 1,679 | $116K | 7/17/2024 | View on chart |
| QCRH | ▲ Buy | Open Market | 1,000 | $56K | 2/5/2024 | View on chart |
| QCRH | ▲ Buy | Option Exercise | 8,112 | $139K | 1/25/2024 | View on chart |
| QCRH | ▼ Sell | Tax Withholding | 4,154 | $254K | 1/25/2024 | View on chart |
| QCRH | ▲ Buy | Open Market | 1,000 | $48K | 10/31/2023 | View on chart |
| QCRH | ▲ Buy | Open Market | 1,000 | $50K | 9/8/2023 | View on chart |
| QCRH | ▲ Buy | Open Market | 1,000 | $51K | 8/23/2023 | View on chart |
| QCRH | ▲ Buy | Open Market | 1,000 | $51K | 7/31/2023 | View on chart |
| QCRH | ▲ Buy | Open Market | 1,000 | $40K | 5/26/2023 | View on chart |
| QCRH | ▲ Buy | Open Market | 1,000 | $39K | 5/2/2023 | View on chart |
| QCRH | ▲ Buy | Option Exercise | 6,002 | $94K | 4/28/2023 | View on chart |
| QCRH | ▼ Sell | Tax Withholding | 3,401 | $141K | 4/28/2023 | View on chart |
| QCRH | ▲ Buy | Open Market | 1,000 | $45K | 3/17/2023 | View on chart |
| QCRH | ▲ Buy | Open Market | 100 | $5K | 12/16/2022 | View on chart |
| QCRH | ▲ Buy | Open Market | 400 | $19K | 12/16/2022 | View on chart |
| QCRH | ▲ Buy | Open Market | 400 | $19K | 12/16/2022 | View on chart |
| QCRH | ▲ Buy | Open Market | 100 | $5K | 12/16/2022 | View on chart |
| QCRH | ▼ Sell | Tax Withholding | 1,506 | $85K | 12/27/2021 | View on chart |
| QCRH | ▲ Buy | Option Exercise | 3,597 | $33K | 12/27/2021 | View on chart |
| QCRH | ▲ Buy | Option Exercise | 3,500 | $33K | 12/15/2021 | View on chart |
| QCRH | ▼ Sell | Tax Withholding | 1,477 | $81K | 12/15/2021 | View on chart |
| QCRH | ▲ Buy | Option Exercise | 4,000 | $37K | 11/15/2021 | View on chart |
| QCRH | ▼ Sell | Tax Withholding | 1,668 | $95K | 11/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
QCRH Earnings Estimates Slightly Higher Ahead of Report
Analysts expect QCR Holdings to report earnings that are slightly above recent estimates. This modest positive outlook comes as the stock trades near its 52-week high range, with an average analyst price target of $110.50. The company's current valuation remains low relative to its peers, supported by a trailing P/E ratio of 11.2.
QCRH Earnings Estimates Slightly Higher Ahead of Report. Analysts expect QCR Holdings to report earnings that are slightly above recent estimates. This modest positive outlook comes as the stock trades near its 52-week high range, with an average analyst price target of $110.50. The company's current valuation remains low relative to its peers, supported by a trailing P/E ratio of 11.2.